Paediatric Consumer Health in Australia

Paediatric Consumer Health in Australia
Compared with previous years, the rate of vaccination for children in Australia has declined in 2023, leaving the younger demographic more vulnerable to colds and flu. Given the nation endured an extended influenza season, sickness amongst children was high, due to the lower level of vaccination. This resulted in high demand for paediatric medicines, especially the key paediatric analgesics – acetaminophen and ibuprofen. The attitude towards vaccination amongst Australians has shifted post COVID...

Euromonitor International's Paediatric Consumer Health in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop